Ubiplug designs easy-to-use medical devices to enhance the healthcare of patients undergoing vascular access. Hemodialysis is the first application of the company’s proprietary technology, Hemoplug™, a platform aimed at transforming how health practitioners care for end-stage renal patients. Ubiplug’s new smart valve system makes it easier to perform vascular access. This single-connection device manages all the necessary steps required to carry out a standard Central Venous Catheter (CVC) procedure. In practice, this means that a nurse directly handles the catheter only once, as opposed to the multiple hand maneuvers usually made around the catheter. This minimizes patient exposure to the main sources of potentially life-threatening infections. Founded in 2017 in Caen, France, Ubiplug has raised close to €3M. It collaborates with the university hospital CHU Caen, AP-HP (Europe’s largest public hospital system located in Paris), and Air Liquide Healthcare, among other industrial and hospital partners, in conceptualizing valve system-based innovations for improved healthcare. The company employs 10 staff.